Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
0.3537
+0.0177 (5.27%)
May 6, 2026, 10:33 AM EDT - Market open
Gossamer Bio Market Cap
Gossamer Bio has a market cap or net worth of $83.01 million as of May 6, 2026. Its market cap has decreased by -55.06% in one year.
Market Cap
83.01M
Enterprise Value
144.83M
1-Year Change
-55.06%
Ranking
Category
Stock Price
$0.35
Market Cap Chart
Since February 8, 2019, Gossamer Bio's market cap has decreased from $995.26M to $83.01M, a decrease of -91.66%. That is a compound annual growth rate of -29.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 78.86M | -89.01% |
| Dec 31, 2025 | 717.51M | 250.03% |
| Dec 31, 2024 | 204.99M | -0.34% |
| Dec 29, 2023 | 205.69M | 0.56% |
| Dec 30, 2022 | 204.54M | -76.06% |
| Dec 31, 2021 | 854.34M | 21.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PolyPid | 85.49M |
| MAIA Biotechnology | 84.33M |
| eXoZymes | 84.11M |
| Acrivon Therapeutics | 84.08M |
| Pelthos Therapeutics | 83.28M |
| aTyr Pharma | 82.65M |
| Champions Oncology | 81.79M |
| Gain Therapeutics | 80.26M |